Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong
· Delayed Price · Currency is HKD 3.650
-0.010 (-0.27%)
At close: Mar 10, 2026
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.33 billion as of March 10, 2026. Its market cap has decreased by -87.25% in one year.
Market Cap
1.33B
Enterprise Value
762.19M
Revenue
58.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.65
Market Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.33B, a decrease of -82.40%. That is a compound annual growth rate of -72.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.33B | -25.15% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.37B |
| CANbridge Pharmaceuticals | 1.39B |
| Kintor Pharmaceutical | 1.44B |
| Immunotech Biopharm | 1.45B |
| Shanghai Bio-heart Biological Technology | 1.20B |
| Mabpharm | 1.69B |
| Wuhan YZY Biopharma | 1.10B |
| Cutia Therapeutics | 1.71B |